News Releases

A report in Cancer Research highlights a new biomarker that may be useful in identifying patients with recurrent glioblastoma who would respond better to antiangiogenesis therapy.

Biomarkers Predict Brain Tumor’s Response to Therapy

23/Jun/2009

A report in Cancer Research, a journal of the American Association for Cancer Research, highlights a new biomarker that may be useful in identifying patients with recurrent glioblastoma, or brain tumors, who would respond better to anti-vascular endothelial growth factor therapy, specifically cediranib.

Link to full AACR release.

Media Contacts: Sue McGreevey, smcgreevey@partners.org, 617 724-2764

patient

U.S. News and World Report Best Hospitals 2015-2016

U.S. News & World Report ranks Mass General the #1 hospital in America based on our quality of care, patient safety and reputation in 16 different specialties. Learn more about why we're #1

Search the Mass General news archive

Search the archive for previously published news articles, press releases and publications.

View all departments

Departments and Centers at Mass General have a reputation for excellence in patient care. View a list of all departments.